Complementation analysis of carnitine palmitoyltransferase I and II defects

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Carnitine palmitoyltransferase (CPT) comprises CPT I and CPT II, located in mitochondrial membranes.
• CPT II deficiency is linked to CPT II cDNA mutations, but the genetic basis of CPT I deficiency remains unknown.

Purpose of the Study:

• To investigate the genetic basis of Carnitine palmitoyltransferase I (CPT I) deficiency.
• To determine if CPT I and CPT II deficiencies arise from mutations in the same or distinct genes.

Main Methods:

• Complementation experiments using cell fusions between CPT I-deficient and infantile CPT II-deficient cell lines.
• Assessing the restoration of 3H2O release from [9,10(n)-3H]-palmitate as a complementation criterion.
• Coculture experiments to observe effects on palmitate oxidation.

Main Results:

• Complementation occurred between CPT I- and CPT II-deficient cells, indicating distinct genetic defects.
• No complementation was observed in fusions of CPT I-deficient or CPT II-deficient cells, suggesting mutations within the same gene for each deficiency type.
• Palmitate oxidation was reduced in cocultures with infantile CPT II-deficient cells, a carnitine-dependent effect.

Conclusions:

• CPT I and CPT II deficiencies result from mutations in separate genes.
• The findings differentiate the genetic origins of CPT I and CPT II deficiencies.
• A carnitine-dependent mechanism may influence fatty acid oxidation in CPT II deficiency.